Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-15 FOEHR MATTHEW W President and COO Shares withheld for taxes −1,090 $123.68 $135K 170,854
2022-02-15 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −1,946 $123.68 $241K 344,570
2022-02-15 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −2,061 $123.68 $255K 342,509
2022-02-15 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −1,916 $123.68 $237K 340,593
2022-02-15 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −906 $123.68 $112K 46,807
2022-02-15 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −969 $123.68 $120K 45,838
2022-02-15 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −1,532 $123.68 $189K 44,306
2022-01-26 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +4,803 44,493
2022-01-26 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +6,848 51,341
2022-01-26 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −1,319 $113.68 $150K 50,022
2022-01-26 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −2,309 $113.68 $262K 47,713
2022-01-26 HIGGINS JOHN L Chief Executive Officer Grant or award +9,606 344,701
2022-01-26 HIGGINS JOHN L Chief Executive Officer Grant or award +13,560 358,261
2022-01-26 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −3,060 $113.68 $348K 355,201
2022-01-26 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −6,183 $113.68 $703K 349,018
2022-01-26 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +2,401 30,292
2022-01-26 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +3,836 34,128
2022-01-26 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −830 $113.68 $94K 33,298
2022-01-26 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −1,326 $113.68 $151K 31,972
2022-01-26 FOEHR MATTHEW W President and COO Grant or award +5,604 172,129

Page 31 of 43 · 858 trades